Dr. Orland Diez completed his PhD in Biology at University of Barcelona (1982), the Especiality in Clinical Biochemistry by the Ministry of Health (1992) and the Acreditation in Human Genetics by the Spanish Association of Human Genetics (2002).

He has been working in different hospital laboratories and research institutes in Barcelona. He has headed the Oncogenetics Group of the Vall d’Hebron Oncological Institute (VHIO) from 2007 to 2018, and now is a senior Investigator of the Hereditary Cancer Genetics Group in VHIO. He is also a Staff member of the Molecular Genetics laboratory in the Clinical and Molecular Genetics Area of ​​the Vall d’Hebron University Hospital since 2007, heading the área of hereditary cancer studies.

He has almost 30 years of experience in the molecular study of genes involved in hereditary cancers and is author of more than 200 national and international publications and book chapters. His research focuses mainly on the identification and characterization of genes related to predisposition to familial cancer syndromes.

He is a member of a number of international consortiums for the identification of new cancer genes, characterization of genetic variants and other aspects related to hereditary cancer. He is also a member of the Molecular Genetics Commission of the Spanish Society of Laboratory Sciences (SEQC) and the Committee on Clinical Molecular Biology Curriculum of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

He has been professor in numerous courses and masters at different research centers and universities, and participated in scientific dissemination activities, as well as in evaluation commissions of scientific projects and auditing national agencies.